Diffusion‐weighted magnetic resonance imaging for detecting and assessing ileal inflammation in <scp>C</scp>rohn's disease
2013 · Alimentary Pharmacology & Therapeutics · 195 citations
https://doi.org/10.1111/apt.12201
A
Anthony Buisson
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
491
Papers
7.0K
Citations
46
h-index
127
i10-index
Anthony Buisson is an academic researcher from Inserm. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Autoimmune and Inflammatory Disorders. The author has an h-index of 46, co-authored 418 publications.
ORCID: 0000-0002-6347-409XPapers by this author
worksInflammatory gastrointestinal diseases associated with PD-1 blockade antibodies
2017 · Annals of Oncology · 152 citations
https://doi.org/10.1093/annonc/mdx403
Prominence of ileal mucosa-associated microbiota to predict postoperative endoscopic recurrence in Crohn’s disease
2019 · Gut · 115 citations
https://doi.org/10.1136/gutjnl-2019-318719
Early Transmural Response Assessed Using Magnetic Resonance Imaging Could Predict Sustained Clinical Remission and Prevent Bowel Damage in Patients with Crohn’s Disease Treated with Anti-Tumour Necrosis Factor Therapy
2020 · Journal of Crohn s and Colitis · 41 citations
https://doi.org/10.1093/ecco-jcc/jjaa098
Propionate catabolism by CD-associated adherent-invasive <i>E. coli</i> counteracts its anti-inflammatory effect
2021 · Gut Microbes · 33 citations
https://doi.org/10.1080/19490976.2020.1839318
Long-term Outcome of Risankizumab in Crohn’s Disease: a Real-world GETAID Study
2024 · Clinical Gastroenterology and Hepatology · 20 citations
https://doi.org/10.1016/j.cgh.2024.04.016
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat